In cannabis, the all-repressive does not work. So let's get out of this expensive and inefficient policy. "L'Obs" launches with more than 70 economists, doctors, politicians a call for a framed legalization. Priority objectives: protection of minors, safety and public health.
The call of "Obs"
We must end the status quo. France must legalize cannabis, whether used for therapeutic or recreational purposes, for consumers over 18 years of age. While its neighbors (Belgium, Germany, Spain, Portugal, the Netherlands …) have all relaxed their legislation, that Canada, Uruguay and several US states have legalized the substance, France is lagging behind. It is bent on a repressive law dating from 1970, totally ineffective since we are the country of the European Union where consumption is highest. From 18 to 64 years old, one in two French people has already tried cannabis, and one in nine adults is a regular user. At 17, 48% of young people have already taken it. At the same age, almost one in ten is a regular user and one in twelve is considered dependent or suffering from problematic use (1).
From a public health point of view, this prohibition seems difficult to justify. while cannabis is less dangerous, once the brain is formed (2), than alcohol, which prematurely kills 41,000 people each year and tobacco, 73,000 (3). We know that it is not a neutral product, but it is precisely because it is harmful to health, particularly that of minors, that production and distribution must be controlled.
Prohibition contributes to unnecessarily clog the activity of magistrates and police: more than 130,000 people are arrested each year for having consumed (4).
In the United States, legalization in several states has reduced crime along the Mexican border (5). When will France accept to face reality, to be pragmatic in the face of this stalemate? The public authorities must act. And quick.
(1) Key figures of the French Observatory of Drugs and Drug Addiction 2017.
(2) Report by Bernard Roques, research director at Inserm, on the classification of psychotropic substances (1998).
(3) Christophe Bonaldi (Public Health France), Catherine Hill (epidemiology Gustave-Roussy).
(4) Central Office for the Suppression of the Illicit Traffic in Narcotic Drugs.
(5) Is Legal Pot Crippling Mexican Drug Trafficking Organizations? The Effect of Marijuana Medical Laws on US Crime, "The Economic Journal.
Patrick Aeberhard Cardiologist, former president of Médecins du Monde
Ingela Alger Economist, researcher at the TSE *, director of research at CNRS
Stefan Ambec Researcher at TSE *, research director at INRA
Gil Avérous Mayor of Châteauroux (LR)
Jean-Paul Azam Researcher at the TSE *, professor of economics, University Toulouse-I Capitole
Laurent Baron Mayor of Pré-Saint-Gervais (PS)
Jacques Bascou President (PS) of the agglomeration community of Narbonne
Julien Bayou Regional Councilor, Spokesperson (EELV)
Esther Benbassa Senator of Paris (EELV)
Christian Ben Lakhdar Professor of Economics at the University of Lille
Amine Benyamina Addictologist
Ugo Bernalicis Member of the North (LFI)
Yann Bisiou Lecturer in private law at Paul-Valéry University Montpellier-III
Jacques Boutault Mayor of 2e arrondissement of Paris (EELV)
Jean-Paul Bret Mayor of Villeurbanne (PS)
Frederic Cherbonnier Economist, researcher at the TSE *, professor at the Institute of Political Studies of Toulouse
Renaud Colson Lawyer, Lecturer at the University of Nantes
Alexis Corbière Member of Parliament for Seine-Saint-Denis (LFI)
David Cormand MEP, National Secretary of EELV
Magali Croset-Calisto Psycho-addictologist
Gérard Cosme President of East Ensemble
Jean-Pierre Daulouède Psychiatrist addictologist
Marie Debrus Pharmacist, Doctors of the World
Philippe De Donder Researcher at the TSE *
William Delannoy Mayor of Saint-Ouen (UDI)
Karima Delli MEP (EELV)
Jacques Delpla Economist, associate professor at the TSE *
Tony Di Martino Mayor of Bagnolet (PS)
Caroline Fiat Member of Parliament for Meurthe-et-Moselle (LFI)
Michel Fourcade Mayor of Pierrefitte-sur-Seine (PS)
Robert Gary-Bobo Professor of Economics Crest-Ensae
Stéphane Gatignon Former Mayor of Sevran
Raphael Glucksmann Member of the European Parliament (PS-Place public)
Christian Gollier Director General of the TSE *
Benoît Hamon Former Minister of National Education
Mathieu Hanotin Departmental Advisor of Seine-Saint-Denis, former Member of Parliament for Seine-Saint-Denis (PS)
Olivia Hicks Doctor and first deputy mayor of 2e district of Paris
Touria Jaaidane Professor of Economics at the University of Lille
Yannick Jadot MEP (EELV)
Pierre Jouvet President of Porte de DrômArdèche, PS spokesman
Laurent Karila Psychiatrist
Michel Kazatchkine Former Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria
Bertrand Kern Mayor of Pantin (PS)
Olivier Klein Mayor of Clichy-sous-Bois (PS)
Gaspard Koenig President of GenerationLibre think tank
Bernard Kouchner Former Minister of Health
Annie Lahmer Regional Advisor of Ile-de-France (EELV)
François-Michel Lambert Member of the Bouches-du-Rhône (formerly LREM)
Bertrand Lebeau Addictologist
William Lowenstein Doctor, President of SOS Addictions
Thierry Magnac Researcher at TSE *, professor of economics at Toulouse-I Capitole University
Patrick Mennucci Councilor of Marseille
Alain Morel Psychiatrist, addictologist, general director of the association Oppelia
Claire Nouvian Environmental activist
Danièle Obono Member of Parliament for Paris (LFI)
Mathilde Panot Member of Parliament for Val-de-Marne (LFI)
Person's Stone Member of Parliament for Paris (LREM)
Emmanuelle Peyret Addictologist, Robert Debré Hospital
Eric Piolle Mayor of Grenoble (EELV)
Collective Police against Prohibition (PCP)
Adrien Quatennens Member of the North (LFI)
Jérôme Renault Researcher at TSE *, Professor of Applied Mathematics at Toulouse-I Capitole University
Régis Renault Professor of Economics at the University of Cergy-Pontoise
Sabine Rubin Member of Parliament for Seine-Saint-Denis (LFI)
Hervé Saulignac Deputy of the Ardèche (PS)
Paul Seabright Researcher at the TSE *
Guy Sebbah Doctor, member of the Executive Board of the SOS Solidarités Group
Beatrice Stambul Psychiatrist
Jennifer Stephenson Communications Officer of the JJ Laffont Foundation and the TSE *
SOUTH Interior Police Union
Aurélien Taché Member of Parliament for Val-d'Oise (LREM)
Benedict Taurine Deputy of Ariège (LFI)
Magalie Thibault Vice-president of the department of Seine-Saint-Denis
Sylvine Thomassin Mayor of Bondy (PS)
Khalid Tinasti Executive Secretary of the Global Commission on Drugs
Ludovic Toro Doctor and mayor of Coubron (UDI), regional advisor of Ile-de-France, member of the commission for coordination of health policies with the ARS
Marie Toussaint MEP (EELV)
Stéphane Troussel President of the department of Seine-Saint-Denis (PS)
Daniel Vaillant Former Minister of the Interior (PS)
Thierry Verdier Professor of Economics (ENPC-ParisTech and Paris School of Economics)
Michèle Victory Member of Parliament for Ardèche (PS)
* Toulouse School of Economics
Here’s what you need to know before visiting your regional medical dispensary:You may need a physician’s recommendation, medical cannabis certification, and/or whatever proper documentation is required by your condition. Typically, you must be 18 or older to qualify for a medical consent, but exceptions could be made in some states for minors with especially debilitating conditions. You will often enroll with a medicinal dispensary. This is to keep your medical cannabis recommendation or certification on file for regulatory and legal purposes. There’ll be a waiting room. This will be to control the circulation of patients and product, but a simple dividing wall gives patients solitude and direct one-on-one contact using a budtender to candidly discuss medical problems. Many times, but not always, your purchases will be monitored by medical dispensaries. This procedure can help budtenders and patients monitor effective medication as well as have a living record of manufacturers and goods for future reference and follow-up. Medicinal dispensaries usually allow you to smell and examine the buds before purchase. This may differ from state-to-state.
Yes, municipal approval is required before the AGLC will subject a retail cannabis license. Applicants must get in touch with their intended municipality to learn requirements concerning municipal retail cannabis laws, zoning requirements, land-use limitations, and location requirements regarding how close a retail shop can be to a provincial health care centre, college, or parcel of property designated as a school reserve.
Keep non-medical cannabis legal Adults who are 19 years or older are in a position to:Possess up to 30 gram of authorized dried cannabis or the equivalent in their own person. Share up to 30 g of legal cannabis with other adults in Canada. Purchase cannabis goods from a Yukon Liquor Corporation licensed retailer. Grow up to four crops per family. It’s illegal to present non invasive cannabis to anyone under the age of 19 and also for anybody under the age of 19 to possess any quantity of anti inflammatory cannabis in Yukon.It is illegal and dangerous to drive while under the influence of cannabis or other intoxicants.